Financials
Income statement
| Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
| Total reported revenue | — | 4.4B | 3.2B | 3.4B |
| Cost of revenue | — | 12M | 12M | 13M |
| Gross profit | — | 4.4B | 3.2B | 3.4B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 461M | 426M | 415M |
| Other operating expenses | — | 428M | 380M | 370M |
| Operating income | — | 1.1B | 273M | 447M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | — | 1.5B | 416M | 512M |
| Tax provision | — | 496M | 141M | 189M |
| Net income | — | 1.0B | 275M | 323M |
| Basic EPS | 13.2 | — | — | — |
| Diluted EPS | 13.2 | — | — | — |
| Basic average shares | 64.2M | — | — | — |
| Diluted average shares | 64.2M | — | — | — |
| EBITDA | — | 778M | 361M | 534M |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | 0 | 0 | 0 |